Short Hairpin RNA Interference Therapy for Ischemic Heart Disease
Author(s) -
Mei Huang,
Denise A. Chan,
Fangjun Jia,
Xiaoyan Xie,
Zongjin Li,
Grant Hoyt,
Robert C. Robbins,
Xiaohong Chen,
Amato J. Giaccia,
Joseph C. Wu
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.760785
Subject(s) - small hairpin rna , microbiology and biotechnology , genetic enhancement , transfection , medicine , rna interference , gene silencing , myocyte , adeno associated virus , rna , gene , biology , recombinant dna , biochemistry , vector (molecular biology)
During hypoxia, upregulation of hypoxia inducible factor-1 alpha transcriptional factor can activate several downstream angiogenic genes. However, hypoxia inducible factor-1 alpha is naturally degraded by prolyl hydroxylase-2 (PHD2) protein. Here we hypothesize that short hairpin RNA (shRNA) interference therapy targeting PHD2 can be used for treatment of myocardial ischemia and this process can be followed noninvasively by molecular imaging.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom